DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,780 | +3.4% | 19,265 | 0.0% | 0.56% | +7.5% |
| Q2 2023 | $4,624 | -43.2% | 19,265 | -40.3% | 0.52% | -42.3% |
| Q1 2023 | $8,134 | +5.8% | 32,272 | +11.5% | 0.91% | -6.6% |
| Q4 2022 | $7,685 | -99.9% | 28,953 | -22.0% | 0.97% | -28.5% |
| Q3 2022 | $9,585,000 | +14.1% | 37,110 | +11.9% | 1.36% | +27.4% |
| Q2 2022 | $8,404,000 | -15.5% | 33,149 | -2.2% | 1.07% | -8.7% |
| Q1 2022 | $9,944,000 | +0.7% | 33,899 | +12.9% | 1.17% | +39.9% |
| Q4 2021 | $9,877,000 | -6.4% | 30,021 | -13.4% | 0.84% | -24.2% |
| Q3 2021 | $10,549,000 | +13.4% | 34,652 | 0.0% | 1.10% | +12.2% |
| Q2 2021 | $9,299,000 | +19.2% | 34,652 | 0.0% | 0.98% | +10.3% |
| Q1 2021 | $7,799,000 | -4.2% | 34,652 | -5.4% | 0.89% | -0.4% |
| Q4 2020 | $8,139,000 | -6.7% | 36,639 | -9.6% | 0.89% | -14.1% |
| Q3 2020 | $8,725,000 | +21.8% | 40,520 | 0.0% | 1.04% | +19.2% |
| Q2 2020 | $7,165,000 | +104.9% | 40,520 | +60.4% | 0.87% | +80.2% |
| Q1 2020 | $3,496,000 | -9.8% | 25,255 | 0.0% | 0.48% | -4.0% |
| Q4 2019 | $3,876,000 | +6.2% | 25,255 | 0.0% | 0.50% | +9.1% |
| Q3 2019 | $3,648,000 | +1.1% | 25,255 | 0.0% | 0.46% | +1.1% |
| Q2 2019 | $3,609,000 | +8.2% | 25,255 | 0.0% | 0.46% | +9.6% |
| Q1 2019 | $3,334,000 | +28.0% | 25,255 | 0.0% | 0.42% | +23.4% |
| Q4 2018 | $2,604,000 | -5.1% | 25,255 | 0.0% | 0.34% | +18.6% |
| Q3 2018 | $2,744,000 | +10.1% | 25,255 | 0.0% | 0.28% | -5.0% |
| Q2 2018 | $2,492,000 | +0.8% | 25,255 | 0.0% | 0.30% | -2.9% |
| Q1 2018 | $2,473,000 | +5.5% | 25,255 | 0.0% | 0.31% | +33.8% |
| Q4 2017 | $2,344,000 | -8.3% | 25,255 | -15.3% | 0.23% | +1.3% |
| Q3 2017 | $2,556,000 | – | 29,801 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |